The line between drug delivery and drug substance will continue to become more elusive in the near future as shown in the analysis in this report, as researchers work to improve drug properties through drug design and molecular modeling. Consequently, in the next decade, drug delivery technologies will be a focal point of competition within the pharmaceutical industry.

This Company report, Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics takes a look at this aspect of the pharmaceutical marketplace with figures and forecasts for pharmaceutical companies and the companies that supply technology to them. The success of specific drugs will be tied to innovative delivery techniques, which will enable the targeting that will exploit the clinical properties of a new generation of drugs.

The needle-free drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to significant improvements in drug delivery. This report looks at that trend and reports current and forecasted revenues for the injectable drug delivery market, segmented into two main categories:

• Needle-Free Products Market (Including Drug and Technology)

• Needle-Free Products Market (Technology Only)

This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. The report also includes information that will be of assistance to business planners:

• Trends in the Vaccine Market

• Market Size and Forecast for Needle-Free Vaccine Technology

• Trends in Biopharmaceuticals

• Leading Pharmaceutical Product Sold With Needle-Free Technologies

• Products in Development

• Detailed Profiles of Key Companies in Needle-Free Technologies.

• Current Market Size and Forecasts to 2013

• Needle-Free Cost Savings, Autojets, Health Care Reform, and Other Trends and Developments

Companies Profiled in the report include:

• Alkermes, Inc.

• ALZA Corp.

• Antares Pharma, Inc.

• Bioject Medical Technologies, Inc.

• CyDex, Inc.

• MGI Pharma, Inc

• Nektar Therapeutics

• Pacira Pharmaceuticals, Inc.

• pSivida

• SurModics, Inc

• Zogenix Corporation

• AP Pharma

• Baxter BioPharma Solutions

• QLT USA, Inc

• Ypsomed Holding AG

The research conducted by Kalorama included comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. New technologies, market developments, and research and development trends and expenditures were identified through patent and database searches, as well as via interviews with key personnel. Person-to-person, email and telephone interviews were the primary method of gathering information.

CHAPTER ONE: EXECUTIVE SUMMARY

• Market Drivers

  • Demographics

  • Pediatrics

• Market Size and Growth

  • Total Needle-free Drug Delivery Market

  • The Needle-free Drug Delivery Only Market

• Competitor and Market Analysis

• Biotech Markets

CHAPTER TWO: INTRODUCTION

• Scope and Methodology

• Drug Delivery Systems

• Phases of Drug Action

  • Pharamcokinetics

• Needle-Free Drug Delivery

  • Auto-injectors

  • Pen Injectors

  • Major Applications

  • Self-Administration

  • Vaccine Delivery

• Safety Concerns

• Local Reactions

• Needle-Free Products

• Review of Major Products on the Market

  • Biojector 2000

  • Vitajet<

  • Injex Drug Delivery System

  • PowderMed

  • Intraject

  • Glide

  • MediJector

  • MiniJect

  • Crossject

  • PenJet

  • Fentanyl ITS

  • PLEASE

CHAPTER THREE: TRENDS AND DEVELOPMENTS

• Pen Injectors

  • Auto-injectors

  • Pen-Prep

  • King

  • KwikPen

  • ImplanJect

  • Bioject ID

• Novel Vaccine Delivery Development

  • Edible Vaccines

  • Mucosal Delivery

  • Intranasal Delivery

  • Vaccine Patches

  • Vaccine Chips

• Delivery Systems Placement Trends

• Nanotechnology

• Drug Delivery Development

• MicroChip Technology

• DNA Vaccines

• Needle-Free Delivery Development

• Medical House/Dr. Reddy’s

• Flugen

• Inviragen

• Other

• Selected Products in Development

CHAPTER FOUR MARKET SIZE AND GROWTH

• Competitive Landscape

• Market Size and Forecast

• Cost Considerations

• Drivers of the Needle-free Drug Delivery Market

• Biologics

• Cancer

• Market

  • Forecast

  • Growth Expectation

• Drug Delivery Development

• MicroChip Technology

• DNA Vaccines

• Needle-Free Delivery Development

• Medical House/Dr. Reddy’s

• Flugen

• Inviragen

• Other

• Selected Products in Development

• Drug Delivery Technology Only Market

• Needle Free Vaccine Delivery Market

  • Childhood Immunization in the United States

  • Childhood Immunization Rates

  • Challenges to the Vaccine Delivery System

  • US Healthcare Reform

  • Market for Pediatric Vaccines

  • Market for Needle-Free Vaccine Delivery Systems

CHAPTER FIVE CONCLUSIONS

• Conclusion 1:

• Conclusion 2:

• Conclusion 3:

• Conclusion 4:

• Conclusion 5:

CHAPTER SiX COMPANY PROFILES

• ALZA Corp.

• DUROS

• ALZAMER

• Antares Pharma, Inc.

• Medi-Jector VISION

• Medi-Jector MJ8

• Vibex

• Aridis Pharmaceuticals, Inc

• Becton Dickinson and Company

• Accuspray

• Revenues

• Bioject Medical Technologies, Inc.

• Jupiter Jet

• Glide Pharma

• ImplaJect

• Intercell AG

• MedImmune, Inc

• Mystic Pharmaceuticals, Inc

• Optinose, Inc

• Pharmajet, Inc

• PowderMed, Inc/Pfizer

• PowderMed

• Ypsomed Holding AG

• ServoPen

• Zogenix Corporation

• Zosano Pharma

APPENDIX: COMPANY DIRECTORY

CHAPTER ONE: EXECUTIVE SUMMARY

• Figure 1-1: Worldwide Market for Needle-Free Delivery

CHAPTER TWO: INTRODUCTION

• Table 2-1: Sequence of Drug Action

CHAPTER THREE: TRENDS AND DEVELOPMENTS

• Table 3-1: Select Products in Development by Drug Delivery Companies

CHAPTER FOUR: MARKET SIZE AND GROWTH

• Table 4-1: Needle-Free Drug Delivery Technology Participants

• Figure 4-1: Cost per Million Injections by Injector Type

• Table 4-2: Worldwide Market for Needle-Free Drug Delivery Technology and Pharmaceuticals 2009-2016

• Figure 4-2: Needle-Free Drug Delivery Technology and Pharmaceuticals 2009-2016

• Figure 4-3: The Worldwide Market for Needle-Free Delivery Systems, Technology Only Revenues, 2009 to 2016

• Table 4-3: The Worldwide Market for Needle-Free Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2009-2016

• Figure 4-4: The Worldwide Market for Needle-Free Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2011

• Table 4-4: Global Immunization Rates by Vaccine Type 2008

• Table 4-5: Immunization Profile of the United States: Population by Age Group, Number of Vaccine-Preventable Diseases Reported by Disease 2002-2008

• Figure 4-6: Pediatric Vaccine Market, 2005-2014

• Figure 4-7: Needle Free Vaccine Delivery Systems Market, 2009-2016